BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 8.06.2017

Bacteriophage Therapy: Scientific and Regulatory Issues; Public Workshop

The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research, and the National Institutes of Health, National Institute of Allergy and Infectious Diseases are announcing a public workshop entitled "Bacteriophage Therapy: Scientific and Regulatory Issues." The purpose of the public workshop is to exchange information with the medical and scientific community about the regulatory and scientific issues associated with bacteriophage therapy.

Source: Federal Register — Food and Drug AdministrationOpen original release →